首页 > 快讯 > 正文

In response to the possible quality risks of some centrally purchased drugs, the National Medical Insurance Administration took the lead in the investigation.

clock
2025-01-20 08:04:45
In response to the possible quality risks of some centrally purchased drugs, the National Medical Insurance Administration took the lead in the investigation.